Locust Wood Capital Advisers’s Boston Scientific BSX Stock Holding History

Locust Wood Capital Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,000	Closed	-$842K	–	49
2022 Q1	$842K	Hold	19,000	–	–	0.05%	42
2021 Q4	$807K	Hold	19,000	–	–	0.04%	46
2021 Q3	$824K	Sell	19,000 -105,200	-85%	-$4.65M	0.04%	46
2021 Q2	$5.31M	Sell	124,200 -5,700	-4%	-$240K	0.31%	44
2021 Q1	$5.02M	Sell	129,900 -6,600	-5%	-$250K	0.3%	41
2020 Q4	$4.91M	Buy	+136,500	New	+$4.92M	0.28%	44

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Locust Wood Capital Advisers's BSX Position: Q3 2022 in Review

Locust Wood Capital Advisers sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 211,643 shares — an estimated $7.89M sold.

Locust Wood Capital Advisers first reported a position in BSX in Q2 2020 and held it in 8 quarters. The position peaked at $88.1M in Q4 2021. 865 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Locust Wood Capital Advisers reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
Locust Wood Capital Advisers sold 211,643 Boston Scientific shares in Q3 2022, an estimated $7.89M.
Locust Wood Capital Advisers first reported a position in Boston Scientific in Q2 2020 and held it in 8 quarters.
Locust Wood Capital Advisers's Boston Scientific position peaked at $88.1M in Q4 2021.
865 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Locust Wood Capital Advisers's 13F filing for Q3 2022, filed 1 Nov 2022.